First Round of Abstract Submission Ends: Jul 30, 2025
Extended Early Bird Ends: Dec 28, 2024
Keynote Speakers
Dr. Xijin Hua
University of Exeter, UK
Title: Innovations in Biomedical Practice: the Integration of Musculoskeletal Modelling and 3D Printed Devices
Dr. Xijin Hua is currently a Lecturer / Assistant Professor in the Department of Engineering at the University of Exeter, UK. Prior to joining the University of Exeter, he obtained his PhD degree from the Institute of Medical and Biological Engineering, School of Mechanical Engineering at the University of Leeds, UK. Subsequently, he served as a European Marie-Curie Individual Fellow, first at ETH Zurich in Switzerland and later at the University of Cambridge in the UK. Dr Hua’s research interests encompass musculoskeletal and tissue biomechanics, human movement analysis, metamaterials, additive manufacturing, and medical devices, including human joint replacements, orthoses, and exoskeletons. Specifically, his research focuses on developing advanced computational modelling and simulation, and integrating these simulations with human movement analysis to investigate the biomechanics of the musculoskeletal system, soft tissue, muscle function and dysfunction, and joint loading. By leveraging 3D printing technology, his research also supports the development of metamaterials by exploring their mechanics and properties, and their applications on the design, development, and manufacturing of medical devices for the prevention and rehabilitation of neuromusculoskeletal disorders, including Parkinson's diseases, cerebral palsy, and joint osteoarthritis. Dr. Hua has published 2 book chapters, over 25 high-impact journal papers, and 20 conference proceedings. He has also been regular reviewer of top scientific journals such as Journal of Biomechanics, Computer Methods and Programs in Biomedicine, Scientific Reports, etc.
Dr. Roderick Slavcev
University of Waterloo School of Pharmacy, Canada
Title: The intelligent Phage-Assembled Gene Expression (iPhAGE) system: a platform for the development of non-invasive, redosable, and targeted gene therapy
Roderick Slavcev is an associate professor with the University of Waterloo’s School of Pharmacy. Dr. Slavcev’s research specializes in bacteriophage-based biotechnology and exploits phage genetic systems and phage themselves in the generation of novel therapeutic platforms. With a particular focus on coliphages, his lab’s research designs and constructs vectors for novel vaccines, gene delivery systems, and immunotherapeutics. In addition, his team identifies and applies novel phage genomic anti-bacterial genes with potential phage therapy applications. Research in the Theraphage lab is heavily multidisciplinary, integrating genetics, molecular biology, microbiology, gene therapy, virology, therapeutic design, and synthetic in vivo biology. Roderick comes to the University of Waterloo with a MBA specialized in biotechnology management and commercialization. As the Professor of Business and Entrepreneurship, Roderick currently directs and delivers the School of Pharmacy's award-winning business curriculum initiative. He was also instrumental in the designing and development of the first Medical Microbiology Laboratory to be offered by a Canadian Pharmacy curriculum and leads the development of a Continuing Education initiative to bring Strategic Management and Leadership to practicing pharmacists. Dr. Slavcev is also the Chief Technology Officer of Mediphage Bioceuticals in Toronto, as well as a Principle Investigator at the Centre for Eye and Vision Research (CEVR) in Hong Kong.
Prof. Ruoxiao Xie
University of Liverpool, UK
Title: Will be update soon
Will update soon.
Dr. Sarah M. Preum
Dartmouth College, USA
Title: Will be Updated soon
Sarah M. Preum is an Assistant Professor in the Computer Science Department at Dartmouth College. She is also an adjunct professor in Biomedical Data Science at the Geisel School of Medicine. She is also a Technical Associate Director at Dartmouth Center for Precision Health and Artificial Intelligence. Sarah develops novel machine learning techniques to enable and enhance computational health. She focuses on natural language processing, temporal modeling, and human-AI interaction to provide safe, personalized decision support for domain-specific digital health applications. To date, her research has resulted in 39 peer-reviewed conference and journal publications. She has published in premier computer science venues, including AAAI, EMNLP, ICWSM, CHI, IMWUT, JMIR, ICDE, PerCom, and ACM Computing Surveys. Sarah has received her Ph.D. in CS from the University of Virginia. Before joining Dartmouth, she was a postdoctoral research scholar in the School of Computer Science at Carnegie Mellon University. Sarah was one of the Rising Stars in EECS in 2020, an international cohort of future female faculties in EECS who demonstrate academic excellence and commitment to advancing equity and inclusion. In addition, she is a recipient of the UVA Graduate Commonwealth Fellowship, the Adobe Research Scholarship, the NSF Smart and Connected Health Student Award, and the UVA Big Data Fellowship. She also serves as an associate editor in ACM Health.
Prof. Chia-Hung Chen
City University of Hong Kong, Hong Kong
Title: Fluidic Multi-Compartmental Protocells for Biomedical Catalysis
Prof. Chia-Hung Chen is a leading expert in soft systems and microfluidic technologies, recognized as one of the top 2% of scholars by Stanford University. His research spans cell-inspired cascade catalysis, smart hydrogels, and single-cell micro/nano-technologies for the functional analysis of cellular heterogeneity in human health and disease. His goal is to develop innovative tools that transform diagnostic and therapeutic strategies for complex human diseases—such as cancer, infectious diseases, and autoimmune disorders—ultimately advancing precision medicine.
Prof. Lipo Wang
Nanyang Technological University, Singapore
Title: Progress in Deep Learning for Medical Image and EEG Classification
Prof. Lipo Wang received the bachelor’s degree from National University of Defense Technology (China) and PhD from Louisiana State University (USA). He is presently with the School of Electrical and Electronic Engineering, Nanyang Technological University, Singapore. His research interest is artificial intelligence for image and data processing. He has 400+ publications, 2 patents and 14,000+ Google Scholar citations. He was keynote speaker for 40+ international conferences. He is an Editor-in-Chief of International Journal of Computational Intelligence and Applications, Senior Editor of IEEE Transactions on Systems, Man, and Cybernetics: Systems, and Associate Editor of IEEE Transactions on Neural Networks and Learning Systems. He is/was Associate Editor/Editorial Board Member of 30+ international journals, including 2 other IEEE Transactions, and guest editor for 10+ journal special issues. He was a member of the Board of Governors of the International Neural Network Society, IEEE Computational Intelligence Society (CIS), and the IEEE Biometrics Council. He served as CIS Vice President for Technical Activities and Chair of Emergent Technologies Technical Committee, as well as Chair of Education Committee of the IEEE Engineering in Medicine and Biology Society (EMBS). He was President of the Asia-Pacific Neural Network Assembly (APNNA, renamed as APNNS – “Society”) and received the APNNA Excellent Service Award. He was founding Chair of both the EMBS Singapore Chapter and CIS Singapore Chapter.
Dr. Sung Ho Lee
CEO, Sunjin Beauty Science, South Korea
Title: Will update soon.
Will update soon.
Prof. Lu Bai
UK
Title: Will update soon.
Will update soon.
Prof. Thomas Ming Swi Chang
Title: Artificial Cells: Innovations and frontiers in Biomedical Engineering
Academic positions Promoted at 3-year intervals from assistant professor to associate professor to full professor of the departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine & Health Sciences, McGill University, Montreal, Quebec, Canada McGill onlu allows full professors to have a limited amount of time for activities outside the university. I requested to be appointed emeritus professor so that I can fulfill the following activities: Director, Artificial Cells & Organs Research Centre, an international centre www.medicine.mcgill.ca/centrechart.pdf Elected Honorary President and coordinator, Artificial Cells, Blood Substitutes & Biotechnology (an international network) www.medicine.mcgill.ca/ISAB.pdf Editor in Chief 1980-2020, Emeritus Editor 2020- Artificial Cells, Nanomedicine & Biotechnology, an international Journal, (Taylor and Frances Publisher) Editor in Chief 2006- Book series on Regenerative Medicine, Artificial Cells & Nanomedicine, World Science Publisher/Imperial College Press, Editor in Chief 2024 International Journal Cell/tissue Engineering, Artificial Cell & Regenerative Medicine Director, " Father of Artificial Cell TMS Chang Academician Specialist Research Station" First Hospital of the Shantou University Medical School.(Shantou is my home town. Honorary Professor, Peking Union Medical College, Chinese Academy of Medical Sciences, China Honorary Professor and chief consultant, Blood Transfusion Institute, Chinese Academy Medical Sciences, China Honorary Professor, Nankai University Publications www.medicine.mcgill.ca/changPub.pdf He has published more than 586 full papers and chapters More than 500 invited lectures and plenary lectures 30 books and special issues
Prof. Shang-Ming Zhou
University of Plymouth, UK
Title: Explainable Artificial Intelligence in Health Data Analytics: Perspectives of System Modelling and Feature Engineering.
Dr. Shang-Ming Zhou is a distinguished Professor of eHealth at the University of Plymouth, UK, where he serves as the Deputy Director of the Centre for Health Technology in the Faculty of Health: Medicine, Dentistry and Human Sciences. Dr. Zhou's work focuses on AI-driven personalized medicine, health informatics, health data science, disease phenotyping, risk stratification, polypharmacy, multimorbidity, and public health research. He leads different projects, advancing AI and machine learning for patient-centric innovations.
Dr. Zhou earned a Ph.D. in Computer Science from the University of Essex in 2006, where his research on machine learning and intelligent data analysis for interpretable data-driven neuro-fuzzy system modelling received high commendation. His PhD research addressed the challenges of Explainability and Transparency of machine learning systems. Now explainable AI (XAI) and machine learning is becoming a hot research topic.
His academic journey also includes an MSc in Applied Mathematics with a specialization in artificial intelligence from Beijing Normal University, China, and a BSc in Mathematics and Education from Liaocheng University, China, all marked with exceptional distinctions.
Over the course of his career, Dr. Zhou has held roles at prestigious institutions, including Chinese Academy of Sciences, Swansea University and the University of Strathclyde. His research has been instrumental in developing cutting-edge AI methods for health risk stratification, multimorbidity analysis, and predictive analytics, supported by substantial grants from international funding bodies such as the EPSRC, MRC. His research on integrating information from multiple sources through advanced methods of type-1 and type-2 OWA operators has paved the way for data integration and aggregation under uncertain environments.
With over 150 peer-reviewed publications, Dr. Zhou is a recognized authority in his field, contributing to editorial boards, technical committees, and academic leadership. Dr. Zhou has received multiple accolades, including: Best Paper Award (Springer Nature) at the International Conference on Frontiers of Intelligent Computing: Theory and Applications; Best Poster Prize at the Royal College of Physicians Annual Conference; Outstanding Academic Service Award (IFIP-WG8.9); Outstanding Reviewer Awards from various journals.
He actively fosters interdisciplinary research in AI and healthcare. His collaborations span academia, industry, and healthcare systems, reflecting his commitment to translating research into impactful clinical and public health solutions.
In addition to his academic achievements, Dr. Zhou is deeply involved in professional organizations like the IEEE and serves on healthcare advisory boards, driving innovation at the intersection of technology and medicine.
Prof. Hassan Zahouani
Ecole Centrale de Lyon, France
Title: Effect of residual tension forces on the wavelength anisometry of 2D imaging of health and pathological human skin.
Hassan Zahouani is a Professor at Ecole Centrale de Lyon since 1991 (Exceptional Class 1 & 2). He is Associate Professor at the University of Halmstad (Sweeden) and President of the Francophone Society of Engineering and of Skin Imaging. In 2022 and 2023 he was ranked by the American University Stanford as one of the 160,000 most cited researchers in the world. In 2023 he was designated as a Fellow of the Carnot Institute in Lyon, for the expertise acquired worldwide in the mechanics and imaging of living tissues. In 2024, Pr H. Zahouani was named a Top Scholar by Sholar GPS. ScholarGPS recognizes Top Scholar for their outstanding performance in various field, Disciplines, and Specialties. The strong publication record of Professor H. Zahouani, the impact of his work and the notable quality of his scholarly contributions placed Professor Hassan Zahouani in the top of 0.5% of all scholars worldwide.
His research work within the Laboratory of Tribology and Dynamics of Systems concerns the mechanics and imaging of living tissues, bio-printed skin, effect of mechanical stimulation of skin in vitro and in vivo, mecano-transduction of living tissue, skin aging, skin natural tension, , and tactile perception.
The development of multi-scale imaging for the analysis and quantification of biophysical markers of tissue sublayers, has been the subject of the development of new multi-scale approaches for the diagnosis and quantification of descriptors of internal tension forces of the different layers of living tissue (LC-OCT tomography, two-photon confocal microscopy, high resolution ultrasound, etc.), It was the birth of digital palpation.
Particular attention has been paid to the superficial fascia that envelops the living tissue. Fascia is the fundamental connective tissue in human life (80th Organ of our Body), it is a fibro-elastic membrane that envelops the entire human anatomical structure. It is now accepted that our body is a fibrillar network from the surface of the skin to the depths of the bone and the cells. Everything is linked by a fibrillar organization whose diameter is extremely variable but continuous in the sense of the mechanics of continuums. Fascia wraps the skin, muscles, nerves, bones, blood vessels, lymphatic system, arteries, spinal cord, brain and organs. Hereditary diseases of the connective tissue or collagenopathies group together diseases by mutation of one of the genes encoding collagen. The main manifestations are abnormalities in the bones, joints, skin, vessels, waist or face. The fascia defined as supporting tissue is probably the source of the natural tension forces of all our human tissues. For skin tissue, the effect of the tension forces of the connective tissue fibrillar network, is visible on the skin surface topography as a network of tension forces from head to foot.
Prof. Vi Khanh Truong
Khalifa University, Abu Dhabi, UAE
Title: Nanostructured Breakthroughs: Paving the Path for Next-Generation Biomedical Devices and Antimicrobial Resistance Mitigation
Dr. Vi Khanh Truong is currently an Associate Professor and Head of NanoBioLab at the Department of Biomedical Engineering and Biotechnology, Khalifa University, where he leverages his expertise in Biomedical Nanoengineering and Nanobiotechnology. He completed his PhD in Nanobiotechnology in 2012 at Swinburne University of Technology. His academic journey includes prestigious fellowships such as the BASF Industrial Postdoctoral Fellowship, CNRS Fellowship, RMIT Vice-Chancellor's Fellowship, and Fulbright Fellowship. Dr. Truong's research focuses intensively on designing multifunctional nanomaterials to enhance the performance of biomedical devices. These materials are specifically engineered to address the escalating risk of device-related infections. His research findings have been published in high-impact journals, including Nature Materials, Nature Communications, Advanced Materials, ACS Nano, and PNAS. With over 170 publications and more than 10,000 citations—an average of over 80 citations per paper—Dr. Truong's contributions are widely recognized, as reflected by his current H-index of 50. In addition to his impactful contributions to the biomedical field, Dr. Truong has applied his expertise to tackle pressing issues in agriculture, food security, and environmental sustainability. His work includes developing agricultural hydrogels and soil-wetting agents with BASF, which address challenges such as drought mitigation and soil degradation. Furthermore, his innovations in nanotechnology have been extended to enhance food preservation techniques and environmental protection strategies, highlighting his commitment to multidisciplinary solutions for global challenges. Dr. Truong holds six patents and has recently filed two additional patents in the areas of immune modulation and anti-infection. His work has led to real-world solutions, including advanced antimicrobial products used in surgeries and hospitals, developed in collaboration with industry leaders such as Global Orthopaedics (now part of Corin Group) and ANISOP Holdings. In addition to his research and industrial engagements, Dr. Truong currently serves as the teaching coordinator, responsible for designing new course topics related to Biomedical Engineering and Biotechnology. His role emphasizes bridging the gap between research and education, aiming to integrate the research-teaching nexus directly into students' learning experiences.
